Jacqueline Vuky

Associate Professor

  • 911 Citations
  • 14 h-Index
20002017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jacqueline Vuky is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Hot Flashes Medicine & Life Sciences
Germ Cell and Embryonal Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
NSC 366140 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2017

  • 911 Citations
  • 14 h-Index
  • 19 Article
14 Citations (Scopus)

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

Michaelson, M. D., Hu, C., Pham, H. T., Dahl, D. M., Lee-Wu, C., Swanson, G. P., Vuky, J., Lee, R. J., Souhami, L., Chang, B., George, A., Sandler, H. & Shipley, W., Apr 1 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 5, p. 995-1001 7 p.

Research output: Contribution to journalArticle

bladder
Paclitaxel
muscles
Urinary Bladder Neoplasms
surgery
215 Citations (Scopus)

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): A multicentre, single-arm, phase 2 study

Balar, A. V., Castellano, D., O'Donnell, P. H., Grivas, P., Vuky, J., Powles, T., Plimack, E. R., Hahn, N. M., de Wit, R., Pang, L., Savage, M. J., Perini, R. F., Keefe, S. M., Bajorin, D. & Bellmunt, J., 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

Cisplatin
Neoplasms
pembrolizumab
Drug Therapy
Comorbidity
16 Citations (Scopus)

Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer

Jones, R., Vuky, J., Elliott, T., Mead, G., Arranz, J. A., Chester, J., Chowdhury, S., Dudek, A. Z., Müller-Mattheis, V., Grimm, M. O., Gschwend, J. E., Wülfing, C., Albers, P., Li, J., Osmukhina, A., Skolnik, J. & Hudes, G., Aug 2013, In : Investigational New Drugs. 31, 4, p. 1001-1007 7 p.

Research output: Contribution to journalArticle

Kinesin
Spindle Apparatus
Safety
Neoplasms
Neutropenia
12 Citations (Scopus)

Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancer

Vuky, J., Corman, J. M., Porter, C., Olgac, S., Auerbach, E. & Dahl, K., 2013, In : Oncologist. 18, 6, p. 687-688 2 p.

Research output: Contribution to journalArticle

docetaxel
Prostatectomy
Prostatic Neoplasms
Immunotherapy
Prostate-Specific Antigen

Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.

Vitolins, M. Z., Griffin, L., Tomlinson, W. V., Vuky, J., Adams, P. T., Moose, D., Frizzell, B., Lesser, G. J., Naughton, M., Radford, J. E. & Shaw, E. G., Nov 10 2013, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31, 32, p. 4092-4098 7 p.

Research output: Contribution to journalArticle

Hot Flashes
Soybean Proteins
Prostatic Neoplasms
Quality of Life
Powders